Transcription of Clostridium difficileInfection Clinical Challengesand ...
{{id}} {{{paragraph}}}
Clostridium difficile ,an anaerobic, spore-forming, toxin-forming, gram-positive bacillus, hasbecome the leading cause of health care associated infectious ,2 The spectrum of C difficileInfection (CDI) ranges from uncomplicated diarrhea to systemic toxic effects markedby sepsis and cases, requiring colectomy, have a mortality rate up to 80%.3 CDI isincreasingly common and causes marked morbidity and mortality, prolonged hospital lengths of stay,and increased health care costs. Recent excess health care costs of hospital-onset CDI are estimated tobe $5042 to $7179 per case, with a national annual estimate (limited to hospital-onset CDI) of $897million to $ emergence of a hypervirulent epidemic strain and community-acquireddisease in populations previously at low risk for CDI most likely will place an even greater burden onpatients and the health care difficileInfectionClinical Challengesand Management StrategiesPAMELA R.
C lostridium difficile,an anaerobic, spore-forming, toxin-forming, gram-positive bacillus, has become the leading cause of health care–associated infectious diarrhea.1,2 The …
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Surveillance, Diagnosis and Management of, Surveillance, Diagnosis and Management of Clostridium difficile, Management of skin and soft tissue, Management of skin and soft tissue infections, Associated, Hygiene Management Guide, Clinical Practice Guidelines for Clostridium, Clinical Practice Guidelines for . Clostridium, Guidelines for Diagnosis, Treatment, and, Clostridium diffi cile, Control of communicable diseases manual, MONUROL